An Array SPRi Biosensor for the Determination of Follicle-Stimulating Hormone in Blood Plasma

• Published in: Sensors
• Main Authors: Anna Sankiewicz, Beata Zelazowska-Rutkowska, Zenon Lukaszewski, Adam Hermanowicz, Ewa Gorodkiewicz
• Format: Article
• Language: English
• Published: MDPI AG 2023-12-01
• Subjects: liquid biopsy; FSH; array SPRi; blood plasma; immunosensor
• Online Access: https://www.mdpi.com/1424-8220/23/24/9686

Follicle-stimulating hormone (FSH) regulates the development, growth, pubertal maturation and reproductive processes of the human body. The determination of serous FSH concentration is significant as an alternative to testicular biopsy in the case of boys suffering from cryptorchidism after orchidopexy, and as a means of determining the menopausal stage in women. The aim of this investigation is to develop a specific array surface plasmon resonance imaging (SPRi) biosensor for the determination of FSH in body liquids such as blood plasma, obtaining sufficient sensitivity to determine FSH at levels characteristic for that hormone in blood plasma, without any signal enhancement. The biosensor consists of a mouse monoclonal anti-FSH antibody attached to the gold surface of a chip via a cysteamine linker. Its linear response range is from 0.08 mIU mL⁻¹ (LOQ) to 20 mIU mL⁻¹, and well covers most of the range of FSH activities found in blood without dilution. The precision of measurement is between 3.2% and 13.1% for model samples, and between 3.7% and 5.6% for spiked plasma samples. Recoveries are in the range from 94% to 108%. The biosensor has good selectivity, and is validated by comparison with ECLE, with good agreement of the results